Australian Clinical Labs
ACL.AX
#7734
Rank
NZ$0.79 B
Marketcap
NZ$4.27
Share price
0.00%
Change (1 day)
38.71%
Change (1 year)

EPS for Australian Clinical Labs (ACL.AX)

EPS in 2025: NZ$0.21

According to Australian Clinical Labs's latest financial reports the company's current EPS (TTM) is NZ$0.21. In 2025 the company made an earnings per share (EPS) of NZ$0.21 an increase over its 2024 EPS that were of NZ$0.15.

EPS history for Australian Clinical Labs from 2021 to 2025

Annual EPS

Year EPS Change
2025NZ$0.2140.51%
2024NZ$0.15-32.69%
2023NZ$0.22-80.47%
2022NZ$1.11105.25%
2021NZ$0.54